Name | |
---|---|
Active Substance | |
Marketing Authorisation Date | .. |
MA Period of Validity | .. |
MA Revocation Date | .. |
Type of prescription | ograničeni recept |
Public Assessment Report | download |
Packaging
Direct Healthcare Professional Communication
Name | Date | Download |
---|---|---|
Pismo zdravstvenim radnicima o povećanom riziku od smrtnosti u bolesnika u dobi 65 godina i mlađih, vezano uz primjenu lijekova koji sadrže deksmedetomidin na jedinicama intenzivnog liječenja | 15.06.2022 | EVER Valinject GmbH, AS Kalceks, Mylan Ireland Limited, Pliva Hrvatska d.o.o., Orion Corporation, Accord Healthcare S.L.U. |